Targeted anti-CCP testing to identify people at risk of rheumatoid arthritis in primary care: an early economic evaluation
Alison F Smith, Bethany Shinkins, Elizabeth M A Hensor, Michelle Wilson, Anna M Anderson, Rebecca Stack, Paul Emery, Kulveer Mankia, Heidi J Siddle · 2026
Read Targeted anti-CCP testing to identify people at risk of rheumatoid arthritis in primary care: an early economic evaluation by Alison F Smith, Bethany Shinkins, Elizabeth M A Hensor, Michelle Wilson, Anna M Anderson, Rebecca Stack, Paul Emery, Kulveer Mankia, Heidi J Siddle (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13626717.txt.
Description
Alison Smith and co-authors weigh the early economics of blood testing to find people at risk of rheumatoid arthritis, in this 2026 study. A marker antibody can appear years before joints swell. Finding at-risk people in primary care could allow earlier, gentler care.
The team simulate ten thousand patients arriving with muscle and joint symptoms. Several testing plans are compared, from testing everyone at once to staged plans. A discrete event model follows patients through to specialist care. Early economics help the health service judge whether wider testing pays. Treating arthritis before damage sets in is far cheaper than late care. The model shows which plan wastes the fewest tests per case found.
Catalog record
| CREATOR | Alison F Smith, Bethany Shinkins, Elizabeth M A Hensor, Michelle Wilson, Anna M Anderson, Rebecca Stack, Paul Emery, Kulveer Mankia, Heidi J Siddle |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 46 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |